These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 32854147)

  • 1. Can a gluten-free diet be partly protective for COVID-19 infection?
    Haupt-Jorgensen M; Buschard K
    APMIS; 2020 Oct; 128(10):558-559. PubMed ID: 32854147
    [No Abstract]   [Full Text] [Related]  

  • 2. Facing the COVID-19 outbreak: What should we know and what could we do?
    Yang Y; Shang W; Rao X
    J Med Virol; 2020 Jun; 92(6):536-537. PubMed ID: 32091134
    [No Abstract]   [Full Text] [Related]  

  • 3. SARS-CoV-2 immunogenicity at the crossroads.
    Karamloo F; König R
    Allergy; 2020 Jul; 75(7):1822-1824. PubMed ID: 32401346
    [No Abstract]   [Full Text] [Related]  

  • 4. Expressions and significances of the angiotensin-converting enzyme 2 gene, the receptor of SARS-CoV-2 for COVID-19.
    Fu J; Zhou B; Zhang L; Balaji KS; Wei C; Liu X; Chen H; Peng J; Fu J
    Mol Biol Rep; 2020 Jun; 47(6):4383-4392. PubMed ID: 32410141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Scientific research progress of COVID-19/SARS-CoV-2 in the first five months.
    Li H; Liu Z; Ge J
    J Cell Mol Med; 2020 Jun; 24(12):6558-6570. PubMed ID: 32320516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sodium status and kidney involvement during COVID-19 infection.
    Post A; Dullaart RPF; Bakker SJL
    Virus Res; 2020 Sep; 286():198034. PubMed ID: 32445872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Testing of natural products in clinical trials targeting the SARS-CoV-2 (Covid-19) viral spike protein-angiotensin converting enzyme-2 (ACE2) interaction.
    Williamson G; Kerimi A
    Biochem Pharmacol; 2020 Aug; 178():114123. PubMed ID: 32593613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of inhaled corticosteroids in asthma and coronavirus disease 2019: Keep calm and carry on.
    Lipworth B; Chan R; Kuo CR
    Ann Allergy Asthma Immunol; 2020 Nov; 125(5):503-504. PubMed ID: 32585180
    [No Abstract]   [Full Text] [Related]  

  • 9. mRNA Vaccines: Possible Tools to Combat SARS-CoV-2.
    Yi C; Yi Y; Li J
    Virol Sin; 2020 Jun; 35(3):259-262. PubMed ID: 32524253
    [No Abstract]   [Full Text] [Related]  

  • 10. The pulmonary-proteoliposome as a new therapeutic approach for Coronaviruses.
    Feliciello I; Procino A
    Hum Vaccin Immunother; 2020 Oct; 16(10):2373. PubMed ID: 32401611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How does SARS-CoV-2 cause COVID-19?
    Matheson NJ; Lehner PJ
    Science; 2020 Jul; 369(6503):510-511. PubMed ID: 32732413
    [No Abstract]   [Full Text] [Related]  

  • 12. Molecular structure analyses suggest strategies to therapeutically target SARS-CoV-2.
    Zhang Y; Kutateladze TG
    Nat Commun; 2020 Jun; 11(1):2920. PubMed ID: 32523109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19 and the nervous system.
    Berger JR
    J Neurovirol; 2020 Apr; 26(2):143-148. PubMed ID: 32447630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19, pulmonary mast cells, cytokine storms, and beneficial actions of luteolin.
    Theoharides TC
    Biofactors; 2020 May; 46(3):306-308. PubMed ID: 32339387
    [No Abstract]   [Full Text] [Related]  

  • 15. Prevention of Severe Coronavirus Disease 2019 Outcomes by Reducing Low-Grade Inflammation in High-Risk Categories.
    Ciornei RT
    Front Immunol; 2020; 11():1762. PubMed ID: 32760408
    [No Abstract]   [Full Text] [Related]  

  • 16. COVID-19 and relative angiotensin-converting enzyme 2 deficiency: role in disease severity and therapeutic response.
    Ryan PM; Caplice N
    Open Heart; 2020 Jun; 7(1):. PubMed ID: 32532804
    [No Abstract]   [Full Text] [Related]  

  • 17. COVID-19 Coronavirus spike protein analysis for synthetic vaccines, a peptidomimetic antagonist, and therapeutic drugs, and analysis of a proposed achilles' heel conserved region to minimize probability of escape mutations and drug resistance.
    Robson B
    Comput Biol Med; 2020 Jun; 121():103749. PubMed ID: 32568687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel coronavirus SARS-CoV-2 (Covid-19) dynamics inside the human body.
    Saha A; Saha B
    Rev Med Virol; 2020 Sep; 30(5):e2140. PubMed ID: 32686248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral submucous fibrosis and COVID-19: Perspective on comorbidity.
    Sarode SC; Sarode GS; Gondivkar S; Gadbail A; Gopalakrishnan D; Patil S
    Oral Oncol; 2020 Aug; 107():104811. PubMed ID: 32505551
    [No Abstract]   [Full Text] [Related]  

  • 20. Vitamin D Supplementation: A Potential Approach for Coronavirus/COVID-19 Therapeutics?
    Arboleda JF; Urcuqui-Inchima S
    Front Immunol; 2020; 11():1523. PubMed ID: 32655583
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.